Geneva Health Forum 2012 Participation Report
date : 4/20/2012
The Geneva Health Forum 2012 was held from the 18-20 April, through cooperation between Geneva University Hospital, Geneva University Faculty of Medicine, and the Swiss Development Cooperation Agency (SDC).
Held since 2006, this latest fourth session was titled ‘A Critical Shift to Chronic Conditions: Learning From the Frontliners’, with discussion being conducted around the theme of non-communicable diseases (NCD), a joint agenda held by both high-income and low-income countries alike.
NCD became the agenda for the U.N. High Level Meeting held in September 2011, however what with this year set to see the determination of an international monitoring hub and goals, the main theme of this forum concerned in what way international cooperation and strategy at the country level should be executed.
On the third day of this forum, HGPI Director Ryoji Noritake also participated as a panelist in the session ‘National & Global Non-Communicable Diseases Platforms: The Best Way Forward’ (20 April, 12:30-14:00). Other panelists included Samantha Battams (Global Health Europe, Global Health Programme, Graduate Institute of International and Development Studies, Geneva, Switzerland), Gaudenz Silberschmidt (International Affairs Division, Swiss Federal Office of Public Health, Bern, Switzerland), Judith Watt (NCD Alliance, London, UK), Olivier Raynaud (World Economic Forum, Geneva, Switzerland), and Ruth Veale (Environment and Safety Department, BEUC [the European Consumers’ Organisation], Brussels, Belgium).
In this session, the importance of bottom-up activities by multi-stakeholders in individual countries together with global cooperation was highlighted in relation to tackling NCD. HGPI’s Ryoji Noritake introduced the directionality for NCD control in accordance with Japan’s re-adjusted local health care plans, and commented on the importance of each country achieving progress through breaking down NCD control into the form of concrete policies, as well as setting global targets.
Finally, it was noted that the NCD issue does not just concern medicine and healthcare but is also an economic and environmental problem. The forum concluded with recognition of the importance and necessity of cooperation and participation from other government agencies concerning the environment, industry and education, in approaching large shared goals.
Held since 2006, this latest fourth session was titled ‘A Critical Shift to Chronic Conditions: Learning From the Frontliners’, with discussion being conducted around the theme of non-communicable diseases (NCD), a joint agenda held by both high-income and low-income countries alike.
NCD became the agenda for the U.N. High Level Meeting held in September 2011, however what with this year set to see the determination of an international monitoring hub and goals, the main theme of this forum concerned in what way international cooperation and strategy at the country level should be executed.
On the third day of this forum, HGPI Director Ryoji Noritake also participated as a panelist in the session ‘National & Global Non-Communicable Diseases Platforms: The Best Way Forward’ (20 April, 12:30-14:00). Other panelists included Samantha Battams (Global Health Europe, Global Health Programme, Graduate Institute of International and Development Studies, Geneva, Switzerland), Gaudenz Silberschmidt (International Affairs Division, Swiss Federal Office of Public Health, Bern, Switzerland), Judith Watt (NCD Alliance, London, UK), Olivier Raynaud (World Economic Forum, Geneva, Switzerland), and Ruth Veale (Environment and Safety Department, BEUC [the European Consumers’ Organisation], Brussels, Belgium).
In this session, the importance of bottom-up activities by multi-stakeholders in individual countries together with global cooperation was highlighted in relation to tackling NCD. HGPI’s Ryoji Noritake introduced the directionality for NCD control in accordance with Japan’s re-adjusted local health care plans, and commented on the importance of each country achieving progress through breaking down NCD control into the form of concrete policies, as well as setting global targets.
Finally, it was noted that the NCD issue does not just concern medicine and healthcare but is also an economic and environmental problem. The forum concluded with recognition of the importance and necessity of cooperation and participation from other government agencies concerning the environment, industry and education, in approaching large shared goals.
Exhibition date:2012-04-20
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
Featured Posts
-
2025-11-13
[Registration Open] (Webinar) The 1st J-PEP Seminar – Initiating Policy Advocacy from Meaningful Involvement (December 8, 2025)
-
2025-12-01
[Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)



